| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |